Vircell Presents Automated Immunoassays and Molecular Diagnostics at MEDICA 2026
Posted on 17 Nov 2026
Vircell (Granada, Spain) is showcasing its portfolio of infectious disease diagnostic solutions at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. At Hall 3, Stand A30, the company is highlighting its VirClia Lotus automated chemiluminescence analyzer, VirClia Monotest assays, AMPLIRUN molecular controls, and Virplex real-time PCR kits. These technologies support clinical laboratories in detecting infectious pathogens while providing flexible testing workflows and quality control solutions.
Among the featured products is VirClia Lotus, a fully automated chemiluminescence immunoassay (CLIA) analyzer designed for infectious disease testing. The system supports random-access testing, continuous loading, and priority processing of urgent samples without requiring batch testing. It accommodates up to 50 primary sample tubes and 79 individual tests onboard, processing 40 tests in 90 minutes, with initial results available in approximately 70 minutes. Automated sample identification, quality control, and bidirectional laboratory information system connectivity help streamline laboratory operations.
The analyzer operates with VirClia Monotest assays, which use individual, ready-to-use test strips for detecting infectious disease markers. The portfolio covers more than 90 parameters across respiratory, gastrointestinal, fungal, viral, and sexually transmitted infections, among others. Each monotest incorporates its own quality control, allowing laboratories to perform individual assays without accumulating samples for batch processing.
A featured assay is the Aspergillus galactomannan ag VirClia Monotest which detects Aspergillus galactomannan antigen in serum, plasma, and bronchoalveolar lavage samples to support the diagnosis of invasive aspergillosis. The automated assay provides results in approximately 75 minutes, including sample pretreatment.
Vircell is also presenting its AmpliRun Total molecular controls for monitoring nucleic acid amplification testing. AmpliRun controls contain quantified, purified, and inactivated microbial genetic material for assessing amplification and detection performance across molecular platforms. AmpliRun Total controls incorporate whole inactivated microorganisms in matrices that mimic clinical specimens, enabling laboratories to assess the complete analytical workflow, including nucleic acid extraction and amplification. The controls are available in lyophilized formats to support stability, handling, and transportation.
Completing the exhibit are the Virplex real-time PCR kits for detecting infectious pathogens in human clinical samples. The portfolio includes multiplex assays targeting respiratory, gastrointestinal, sexually transmitted, and other infections. The kits feature lyophilized master mixes, positive controls, and internal controls to monitor amplification performance and potential inhibition. Available in different formats, including predispensed strips and plates, the assays are compatible with commonly used real-time PCR instruments and can be integrated with automated extraction and analysis workflows. Together, these solutions reflect Vircell's focus on combining flexible infectious disease testing with laboratory automation and quality assurance.